FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2028006649> ?p ?o ?g. }

• W2028006649 endingPage "263" @default.
• W2028006649 startingPage "247" @default.
• W2028006649 abstract "A new formulation of exenatide has become available recently that is the first antidiabetic medication for type 2 diabetes mellitus (T2DM) dosed on a weekly schedule. This review summarizes the pharmacology, efficacy, and safety of exenatide once weekly (exenatide QW). The results are interpreted in terms of the pathophysiology of T2DM, as well as the pharmacology of the new formulation. Relevant literature on exenatide QW and diabetes was identified through PubMed database searches from inception until September 2013. In the new once-weekly formulation of exenatide, the exenatide molecule is dispersed in microspheres. Following subcutaneous injection, these microspheres degrade in situ and slowly release active agent. In clinical trials, therapy with exenatide QW as monotherapy or in combination with other antidiabetic treatments was associated with reductions in glycated hemoglobin (−1.3% to −1.9%), fasting plasma glucose (−32 to −41 mg/dL), and body weight (−2.0 to −3.7 kg). These outcomes were achieved without an associated increase in the rate of hypoglycemic episodes, except when exenatide QW was used in combination with sulfonylureas. The primary tolerability issues in the trials were gastrointestinal adverse events, particularly during the first weeks of use, although the rate of nausea during startup with exenatide QW was lower than that with the related agents, exenatide twice daily and liraglutide once daily. Exenatide QW may be particularly well suited to patients who desire the benefits associated with glucagon-like peptide-1 receptor agonists, including significant glycemic control, low risk of hypoglycemia, and moderate weight loss, but prefer the convenience of once-weekly dosing." @default.
• W2028006649 created "2016-06-24" @default.
• W2028006649 creator A5065884384 @default.
• W2028006649 date "2014-02-18" @default.
• W2028006649 modified "2023-10-06" @default.
• W2028006649 title "Pathophysiological and Pharmacological Rationale for the Use of Exenatide Once Weekly in Patients with Type 2 Diabetes" @default.
• W2028006649 cites W1600685366 @default.
• W2028006649 cites W172609984 @default.
• W2028006649 cites W1887330886 @default.
• W2028006649 cites W1898466139 @default.
• W2028006649 cites W1966372003 @default.
• W2028006649 cites W1967256054 @default.
• W2028006649 cites W1970638723 @default.
• W2028006649 cites W1977102586 @default.
• W2028006649 cites W1983581861 @default.
• W2028006649 cites W1987319592 @default.
• W2028006649 cites W2007886041 @default.
• W2028006649 cites W2008132861 @default.
• W2028006649 cites W2010033044 @default.
• W2028006649 cites W2021929263 @default.
• W2028006649 cites W2024569808 @default.
• W2028006649 cites W2025664641 @default.
• W2028006649 cites W2029145065 @default.
• W2028006649 cites W2032322539 @default.
• W2028006649 cites W2033125833 @default.
• W2028006649 cites W2035321575 @default.
• W2028006649 cites W2043900831 @default.
• W2028006649 cites W2054185381 @default.
• W2028006649 cites W2054925541 @default.
• W2028006649 cites W2057913111 @default.
• W2028006649 cites W2060911425 @default.
• W2028006649 cites W2064130493 @default.
• W2028006649 cites W2072691447 @default.
• W2028006649 cites W2083357334 @default.
• W2028006649 cites W2083534804 @default.
• W2028006649 cites W2096070544 @default.
• W2028006649 cites W2101613382 @default.
• W2028006649 cites W2106036385 @default.
• W2028006649 cites W2106895780 @default.
• W2028006649 cites W2107046282 @default.
• W2028006649 cites W2107949845 @default.
• W2028006649 cites W2109728760 @default.
• W2028006649 cites W2110599879 @default.
• W2028006649 cites W2112573165 @default.
• W2028006649 cites W2112981414 @default.
• W2028006649 cites W2115707749 @default.
• W2028006649 cites W2121496050 @default.
• W2028006649 cites W2127125241 @default.
• W2028006649 cites W2127854619 @default.
• W2028006649 cites W2136254957 @default.
• W2028006649 cites W2137805490 @default.
• W2028006649 cites W2138077952 @default.
• W2028006649 cites W2139485303 @default.
• W2028006649 cites W2151848850 @default.
• W2028006649 cites W2152984355 @default.
• W2028006649 cites W2158762809 @default.
• W2028006649 cites W2162350144 @default.
• W2028006649 cites W2164169548 @default.
• W2028006649 cites W2164469187 @default.
• W2028006649 cites W2164733897 @default.
• W2028006649 cites W2171024875 @default.
• W2028006649 cites W2172204314 @default.
• W2028006649 cites W3021197562 @default.
• W2028006649 cites W4242364069 @default.
• W2028006649 cites W4289253786 @default.
• W2028006649 doi "https://doi.org/10.1007/s12325-014-0101-4" @default.
• W2028006649 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3961598" @default.
• W2028006649 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24535624" @default.
• W2028006649 hasPublicationYear "2014" @default.
• W2028006649 type Work @default.
• W2028006649 sameAs 2028006649 @default.
• W2028006649 citedByCount "10" @default.
• W2028006649 countsByYear W20280066492014 @default.
• W2028006649 countsByYear W20280066492015 @default.
• W2028006649 countsByYear W20280066492016 @default.
• W2028006649 countsByYear W20280066492019 @default.
• W2028006649 countsByYear W20280066492021 @default.
• W2028006649 crossrefType "journal-article" @default.
• W2028006649 hasAuthorship W2028006649A5065884384 @default.
• W2028006649 hasBestOaLocation W20280066491 @default.
• W2028006649 hasConcept C126322002 @default.
• W2028006649 hasConcept C134018914 @default.
• W2028006649 hasConcept C197934379 @default.
• W2028006649 hasConcept C2777180221 @default.
• W2028006649 hasConcept C2777538456 @default.
• W2028006649 hasConcept C2778375690 @default.
• W2028006649 hasConcept C2780473172 @default.
• W2028006649 hasConcept C2780533449 @default.
• W2028006649 hasConcept C2780668416 @default.
• W2028006649 hasConcept C2781308992 @default.
• W2028006649 hasConcept C555293320 @default.
• W2028006649 hasConcept C71924100 @default.
• W2028006649 hasConcept C98274493 @default.
• W2028006649 hasConceptScore W2028006649C126322002 @default.
• W2028006649 hasConceptScore W2028006649C134018914 @default.
• W2028006649 hasConceptScore W2028006649C197934379 @default.
• W2028006649 hasConceptScore W2028006649C2777180221 @default.
• W2028006649 hasConceptScore W2028006649C2777538456 @default.

• next